申请人:Cui Jean Jingrong
公开号:US20060046991A1
公开(公告)日:2006-03-02
Enantiomerically pure compound of formula 1
are provided, as well as methods for their synthesis and use. Preferred compounds are potent inhibitors of the c-Met protein kinase, and are useful in the treatment of abnormal cell growth disorders, such as cancers.
提供了式1的对映纯化合物,以及它们的合成和使用方法。优选化合物是c-Met蛋白激酶的强效抑制剂,并且在治疗异常细胞生长紊乱,如癌症方面具有用处。